BioCentury
ARTICLE | Clinical News

Remimazolam: Phase III started

December 14, 2015 8:00 AM UTC

Paion began a double-blind, U.S. Phase III trial to compare IV remimazolam vs. placebo and open-label midazolam in about 75 high-risk patients undergoing a colonoscopy. Patients will receive 2.5-5 mg ...